Image (203f5024 62db 45d6 97b4 Db723679dc5c 01)
Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 68382-824
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 68382-824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (203f5024 62db 45d6 97b4 Db723679dc5c 02)
Image (203f5024 62db 45d6 97b4 Db723679dc5c 03)
This text is a table showing reduction in Serum Phosphorus levels over a period of time. The first column contains values from -4 to 6, the second column contains values 100, sl, Active control, Active Cont and g 807, the third column contains value Y, and the fourth column contains values 2%, 704, Fc, € 5 60, % S50, 1, 23, 29, and Sxao+ . The fifth column includes the text "§5 » £%301 sevelamer Hydrochloride” and the sixth column includes a graph showing an increase or reduction in the serum phosphorus levels. No further information is available.*
Image (203f5024 62db 45d6 97b4 Db723679dc5c 04)
This appears to be a table or graph showing the change in phosphorus levels from baseline for patients taking Sevelamer Hydrochloride compared to an active control, over the course of a study that lasted at least 52 weeks. However, without more context or clearer formatting, it is difficult to provide more specific information.*
Image (203f5024 62db 45d6 97b4 Db723679dc5c 05)
NDC 68382-824-27 is a package of Sevelamer Carbonate tablets containing 270 film-coated tablets. Each tablet contains 800mg sevelamer carbonate. The package insert contains dosage information. The tablets should be stored between 20°C to 25°C to maintain Controlled Room Temperature. The tablets should be kept in a tight container to protect them from moisture. This medication is manufactured by Cadila Healthcare Ltd. in Anmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc. in Penninglon, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
